Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02448485 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)

Study acronym: TASS-2
StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Unknown → Completed
    • Site details revised
    • Eligibility criteria expanded, about 3 words
  2. Changed Registry marked status Unknown; last known: Recruiting
  3. Trial status: Recruiting to Unknownv10
  4. Re-verified, no change to tracked fieldsv9
  5. Primary and study completion dates: Oct 2022 to Oct 2025v8
Show 6 earlier versionsHide 6 earlier versions
  1. Re-verified, no change to tracked fieldsv7
  2. Enrollment target: 6000 to 10000
    • Primary and study completion dates: Jul 2019 to Oct 2022
    v6
  3. Enrollment target: 3000 to 6000
    • Primary and study completion dates: Jul 2018 to Jul 2019
    v5
  4. Enrollment target: 1100 to 3000v4 Show 4 more changesShow less
    • Primary and study completion dates: Jul 2015 to Jul 2018
    • Trial status: Completed to Recruiting
    • Site details revised
    • Eligibility criteria expanded, about 1 word
  5. Trial status: Not Yet Recruiting to Completed
    • Primary completion date changed from estimate of Sep 2015 to Jul 2015
    • Study completion date changed from estimate of Oct 2015 to Jul 2015
    v3
  6. Study title expanded, about 10 wordsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
TASS-2 (Tyrolean Aortic Stenosis Study-2) aims to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.
Trial Details
NCT Number NCT02448485
Lead Sponsor Medical University Innsbruck
Conditions
(from sponsor)		 Aortic Stenosis, Heart Failure, Syncope, Angina Pectoris
Related terms Angina Pectoris, Aortic Valve Stenosis, Heart Failure, Syncope
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov